1. Home
  2. BIAF
  3. BIAF News

Latest bioAffinity Technologies Inc. (BIAF) News on January 23, 2025

bioAffinity Technologies Announces Acceptance of Patent Application for Early-Stage Lung Cancer Diagnostic
BIAF

Business Wire

14 hours ago

bioAffinity Technologies Announces Acceptance of Patent Application for Early-Stage Lung Cancer Diagnostic

bioAffinity Technologies Reports Positive Results from Texas Beta Launch of CyPath® Lung
BIAF

Business Wire

10 days ago

bioAffinity Technologies Reports Positive Results from Texas Beta Launch of CyPath® Lung

Enlivex Therapeutics and bioAffinity Technologies Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
BIAF

ACCESSWIRE

13 days ago

Enlivex Therapeutics and bioAffinity Technologies Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

bioAffinity Technologies Boosts Sales with CyPath Lung
BIAF

TipRanks

a month ago

bioAffinity Technologies Boosts Sales with CyPath Lung

Join bioAffinity Technologies’ Exclusive Live Investor Webinar and Q&A Session on Thursday, December 19
BIAF

Business Wire

a month ago

Join bioAffinity Technologies’ Exclusive Live Investor Webinar and Q&A Session on Thursday, December 19

bioAffinity Technologies Set for Continued Expansion in 2025
BIAF

Business Wire

a month ago

bioAffinity Technologies Set for Continued Expansion in 2025

Veterans’ Research Foundation Spotlights CyPath® Lung’s Addition to the Federal Supply Schedule
BIAF

Business Wire

2 months ago

Veterans’ Research Foundation Spotlights CyPath® Lung’s Addition to the Federal Supply Schedule

bioAffinity Technologies Reports $2.4 Million Revenue for Q3 2024
BIAF

Business Wire

2 months ago

bioAffinity Technologies Reports $2.4 Million Revenue for Q3 2024

bioAffinity Technologies Appoints New Chief Science Officer to Spearhead Product Development
BIAF

Business Wire

3 months ago

bioAffinity Technologies Appoints New Chief Science Officer to Spearhead Product Development

BIAF

MT Newswires

3 months ago

bioAffinity Technologies Secures Japanese Patent for Lung Cancer Diagnostic Method

bioAffinity Technologies Announces Award of Japanese Patent for CyPath® Lung
BIAF

Business Wire

3 months ago

bioAffinity Technologies Announces Award of Japanese Patent for CyPath® Lung

WallachBeth Capital Announces Closing of bioAffinity Technologies $2.6 Million Registered Direct Offering & Concurrent Private Placement
BIAF

PR Newswire

3 months ago

WallachBeth Capital Announces Closing of bioAffinity Technologies $2.6 Million Registered Direct Offering & Concurrent Private Placement

bioAffinity Technologies Announces Closing of $2.6 Million Registered Direct Offering & Concurrent Private Placement
BIAF

Business Wire

3 months ago

bioAffinity Technologies Announces Closing of $2.6 Million Registered Direct Offering & Concurrent Private Placement

WallachBeth Capital Announces Pricing of bioAffinity Technologies $2.66 Million Registered Direct Offering & Concurrent Private Placement
BIAF

PR Newswire

3 months ago

WallachBeth Capital Announces Pricing of bioAffinity Technologies $2.66 Million Registered Direct Offering & Concurrent Private Placement

bioAffinity Technologies Announces Pricing of $2.66 Million Registered Direct Offering & Concurrent Private Placement
BIAF

Business Wire

3 months ago

bioAffinity Technologies Announces Pricing of $2.66 Million Registered Direct Offering & Concurrent Private Placement

bioAffinity’s CyPath® Lung Cancer Test Supported by Newly Published Flow Cytometry Guidelines
BIAF

Business Wire

3 months ago

bioAffinity’s CyPath® Lung Cancer Test Supported by Newly Published Flow Cytometry Guidelines

BIAF

MT Newswires

3 months ago

BioAffinity Technologies Appoints J. Michael Edwards as CFO

bioAffinity Technologies Names J. Michael Edwards as Chief Financial Officer
BIAF

Business Wire

3 months ago

bioAffinity Technologies Names J. Michael Edwards as Chief Financial Officer

bioAffinity Technologies Awarded U.S. Federal Supply Schedule Contract for CyPath® Lung Test
BIAF

Business Wire

3 months ago

bioAffinity Technologies Awarded U.S. Federal Supply Schedule Contract for CyPath® Lung Test

Peer-Reviewed Study: bioAffinity Technologies’ CyPath® Lung Test Shows Potential Significant Healthcare Savings by Reducing Unnecessary Follow-Up, Medical Complications and Overdiagnosis
BIAF

Business Wire

4 months ago

Peer-Reviewed Study: bioAffinity Technologies’ CyPath® Lung Test Shows Potential Significant Healthcare Savings by Reducing Unnecessary Follow-Up, Medical Complications and Overdiagnosis

bioAffinity Technologies CFO to Depart for New Opportunity; J. Michael Edwards to Return as Interim CFO
BIAF

Business Wire

5 months ago

bioAffinity Technologies CFO to Depart for New Opportunity; J. Michael Edwards to Return as Interim CFO

bioAffinity Technologies Reports $2.4 Million Revenue for Q2 Driven by Growing CyPath® Lung Sales
BIAF

Business Wire

5 months ago

bioAffinity Technologies Reports $2.4 Million Revenue for Q2 Driven by Growing CyPath® Lung Sales

BIAF

MT Newswires

6 months ago

BioAffinity Raises Nearly $1.8 Million From Offerings

bioAffinity Technologies Announces Closing of Registered Direct Offering, Concurrent Private Placement and Warrant Inducement for Aggregate Gross Proceeds of $1.75 Million
BIAF

Business Wire

6 months ago

bioAffinity Technologies Announces Closing of Registered Direct Offering, Concurrent Private Placement and Warrant Inducement for Aggregate Gross Proceeds of $1.75 Million

WallachBeth Capital Announces bioAffinity Technologies Pricing of Registered Direct Offering and Concurrent Private Placement and Warrant Inducement for Aggregate Gross Proceeds of $1.75 Million
BIAF

PR Newswire

6 months ago

WallachBeth Capital Announces bioAffinity Technologies Pricing of Registered Direct Offering and Concurrent Private Placement and Warrant Inducement for Aggregate Gross Proceeds of $1.75 Million

bioAffinity Technologies Announces Pricing of Registered Direct Offering and Concurrent Private Placement and Warrant Inducement for Aggregate Gross Proceeds of $1.75 Million
BIAF

Business Wire

6 months ago

bioAffinity Technologies Announces Pricing of Registered Direct Offering and Concurrent Private Placement and Warrant Inducement for Aggregate Gross Proceeds of $1.75 Million

Biotricity and bioAffinity Technologies Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
BIAF

ACCESSWIRE

6 months ago

Biotricity and bioAffinity Technologies Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

bioAffinity Technologies Reports 217% Sales Growth in Second Quarter 2024 for CyPath® Lung
BIAF

Business Wire

6 months ago

bioAffinity Technologies Reports 217% Sales Growth in Second Quarter 2024 for CyPath® Lung

BioVie and bioAffinity Technologies Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
BIAF

ACCESSWIRE

7 months ago

BioVie and bioAffinity Technologies Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

bioAffinity Technologies Reports Accelerating Growth of Physician Practices Ordering CyPath® Lung Tests
BIAF

Business Wire

7 months ago

bioAffinity Technologies Reports Accelerating Growth of Physician Practices Ordering CyPath® Lung Tests

bioAffinity Technologies Reports Record Q1 Revenue Driven by Accelerating Growth of CyPath® Lung Sales and Increased Laboratory Volumes
BIAF

Business Wire

8 months ago

bioAffinity Technologies Reports Record Q1 Revenue Driven by Accelerating Growth of CyPath® Lung Sales and Increased Laboratory Volumes

bioAffinity Technologies News Update
BIAF

Business Wire

9 months ago

bioAffinity Technologies News Update

bioAffinity Technologies Advances New Product Development Initiatives to Accelerate Next Phase of Growth
BIAF

Business Wire

9 months ago

bioAffinity Technologies Advances New Product Development Initiatives to Accelerate Next Phase of Growth

bioAffinity Technologies Expands Campaign to Support American Cancer Society Initiative for Lung Cancer Screening
BIAF

Business Wire

9 months ago

bioAffinity Technologies Expands Campaign to Support American Cancer Society Initiative for Lung Cancer Screening

bioAffinity Technologies Reports Fourth Quarter and Full Year 2023 Financial Results
BIAF

Business Wire

10 months ago

bioAffinity Technologies Reports Fourth Quarter and Full Year 2023 Financial Results

Wallachbeth Capital Announces Closing of bioAffinity Technologies $2.5 Million Registered Direct Offering and Concurrent Private Placement
BIAF

PR Newswire

10 months ago

Wallachbeth Capital Announces Closing of bioAffinity Technologies $2.5 Million Registered Direct Offering and Concurrent Private Placement

bioAffinity Technologies Announces Closing of $2.5 Million Registered Direct Offering and Concurrent Private Placement
BIAF

Business Wire

10 months ago

bioAffinity Technologies Announces Closing of $2.5 Million Registered Direct Offering and Concurrent Private Placement

WallachBeth Capital Announces Pricing of BioAffinity Technologies $2.5 Million Registered Direct Offering and Concurrent Private Placement
BIAF

PR Newswire

a year ago

WallachBeth Capital Announces Pricing of BioAffinity Technologies $2.5 Million Registered Direct Offering and Concurrent Private Placement

bioAffinity Technologies Announces Pricing of $2.5 Million Registered Direct Offering and Concurrent Private Placement
BIAF

Business Wire

a year ago

bioAffinity Technologies Announces Pricing of $2.5 Million Registered Direct Offering and Concurrent Private Placement

bioAffinity Technologies Reports Accelerating Sales Growth of CyPath® Lung
BIAF

Business Wire

a year ago

bioAffinity Technologies Reports Accelerating Sales Growth of CyPath® Lung

Here's Why We're A Bit Worried About bioAffinity Technologies' (NASDAQ:BIAF) Cash Burn Situation
BIAF

Simply Wall St.

a year ago

Here's Why We're A Bit Worried About bioAffinity Technologies' (NASDAQ:BIAF) Cash Burn Situation

bioAffinity Technologies News Update
BIAF

Business Wire

a year ago

bioAffinity Technologies News Update

Medical Director of Lung Innovations Network and The Lung Center at Penn Highlands Healthcare, Sandeep Bansal, M.D., Joins bioAffinity Technologies’ Medical and Scientific Advisory Board and Incorporates CyPath® Lung into Medical Practice
BIAF

Business Wire

a year ago

Medical Director of Lung Innovations Network and The Lung Center at Penn Highlands Healthcare, Sandeep Bansal, M.D., Joins bioAffinity Technologies’ Medical and Scientific Advisory Board and Incorporates CyPath® Lung into Medical Practice

bioAffinity Technologies In The News
BIAF

Business Wire

a year ago

bioAffinity Technologies In The News

BM Technologies (BMTX) Champions Campus Excellence and Announces 2023 ACE Award and Partnership Winners
BIAF

ACCESSWIRE

a year ago

BM Technologies (BMTX) Champions Campus Excellence and Announces 2023 ACE Award and Partnership Winners

Genius Group and FatBrain AI Agree to Merge into Growth Platform to Accelerate the Exponential Economy of Tomorrow
BIAF

GlobeNewswire

a year ago

Genius Group and FatBrain AI Agree to Merge into Growth Platform to Accelerate the Exponential Economy of Tomorrow

bioAffinity Technologies Announces Award of Therapeutic Patent for Treatment of Cancer
BIAF

Business Wire

a year ago

bioAffinity Technologies Announces Award of Therapeutic Patent for Treatment of Cancer

Orion (OESX) Preliminary Q3 Results Depict Strong Demand
BIAF

Zacks

a year ago

Orion (OESX) Preliminary Q3 Results Depict Strong Demand

MAIA Soars 20% on Interim Results From Lung Cancer Study
BIAF

Zacks

a year ago

MAIA Soars 20% on Interim Results From Lung Cancer Study

MAIA Biotechnology Provides Positive Phase 2 Clinical Updates for Lead Anticancer Agent and Outlines Targeted Milestones for 2024
BIAF

Business Wire

a year ago

MAIA Biotechnology Provides Positive Phase 2 Clinical Updates for Lead Anticancer Agent and Outlines Targeted Milestones for 2024

Glen Burnie Bancorp's (NASDAQ:GLBZ) Dividend Will Be $0.10
BIAF

Simply Wall St.

a year ago

Glen Burnie Bancorp's (NASDAQ:GLBZ) Dividend Will Be $0.10

VYNE Therapeutics Announces Positive Biomarker Data from Successful Phase 1b Trial of VYN201 for the Treatment of Vitiligo
BIAF

GlobeNewswire

a year ago

VYNE Therapeutics Announces Positive Biomarker Data from Successful Phase 1b Trial of VYN201 for the Treatment of Vitiligo

The Container Store lowers Q3 sales guidance
BIAF

Retail Dive

a year ago

The Container Store lowers Q3 sales guidance

bioAffinity Technologies and BioVie Interviews to Air on the RedChip Small Stocks Big Money(R) Show on Bloomberg TV
BIAF

ACCESSWIRE

a year ago

bioAffinity Technologies and BioVie Interviews to Air on the RedChip Small Stocks Big Money(R) Show on Bloomberg TV

VYNE Therapeutics Appoints Christine Borowski, Ph.D., to its Board of Directors
BIAF

GlobeNewswire

a year ago

VYNE Therapeutics Appoints Christine Borowski, Ph.D., to its Board of Directors

3 Penny Stocks to Make You the Millionaire Next Door: 2024 Edition
BIAF

InvestorPlace

a year ago

3 Penny Stocks to Make You the Millionaire Next Door: 2024 Edition

Pacira Appoints Frank D. Lee as Chief Executive Officer
BIAF

GlobeNewswire

a year ago

Pacira Appoints Frank D. Lee as Chief Executive Officer

Innovative Solutions and Support Inc (ISSC) Reports Strong Q4 and Full Year Fiscal 2023 Results
BIAF

GuruFocus.com

a year ago

Innovative Solutions and Support Inc (ISSC) Reports Strong Q4 and Full Year Fiscal 2023 Results

PodcastOne (NASDAQ: PODC) Acquires Exclusive Rights to Hit Podcast Was I In A Cult? From Hosts Liz Iacuzzi and Tyler Measom
BIAF

GlobeNewswire

a year ago

PodcastOne (NASDAQ: PODC) Acquires Exclusive Rights to Hit Podcast Was I In A Cult? From Hosts Liz Iacuzzi and Tyler Measom

Cara Therapeutics Announces Outcome from Dose-Finding Part A of KIND 1 Study Evaluating Oral Difelikefalin for Moderate-to-Severe Pruritus in Patients with Atopic Dermatitis
BIAF

GlobeNewswire

a year ago

Cara Therapeutics Announces Outcome from Dose-Finding Part A of KIND 1 Study Evaluating Oral Difelikefalin for Moderate-to-Severe Pruritus in Patients with Atopic Dermatitis

Pleasing Signs As A Number Of Insiders Buy GeneDx Holdings Stock
BIAF

Simply Wall St.

a year ago

Pleasing Signs As A Number Of Insiders Buy GeneDx Holdings Stock

Kustom Entertainment Inc. and Clover Leaf Capital Corp. Amend the Lock-Up Agreement in their Proposed Business Combination
BIAF

GlobeNewswire

a year ago

Kustom Entertainment Inc. and Clover Leaf Capital Corp. Amend the Lock-Up Agreement in their Proposed Business Combination

Moolec Science to Host First Quarter Fiscal Year 2024 Business Update Conference Call
BIAF

ACCESSWIRE

a year ago

Moolec Science to Host First Quarter Fiscal Year 2024 Business Update Conference Call

Lead Real Estate Co., Ltd Announces Sale of 17-unit Luxury Condominium in Tokyo
BIAF

GlobeNewswire

a year ago

Lead Real Estate Co., Ltd Announces Sale of 17-unit Luxury Condominium in Tokyo

bioAffinity Technologies Appoints Jamie Platt, Ph.D., to its Board of Directors
BIAF

Business Wire

a year ago

bioAffinity Technologies Appoints Jamie Platt, Ph.D., to its Board of Directors

Bolt Biotherapeutics Enrolls First Patient in Phase 2 Clinical Study Evaluating BDC-1001 in Patients with HER2-Positive Breast Cancer Previously Treated with Enhertu®
BIAF

GlobeNewswire

a year ago

Bolt Biotherapeutics Enrolls First Patient in Phase 2 Clinical Study Evaluating BDC-1001 in Patients with HER2-Positive Breast Cancer Previously Treated with Enhertu®

GeneDx Presents New Data at the American Epilepsy Society Annual Meeting Demonstrating That Exome Sequencing Outperforms Multi-Gene Panels for Patients with Epilepsy
BIAF

GlobeNewswire

a year ago

GeneDx Presents New Data at the American Epilepsy Society Annual Meeting Demonstrating That Exome Sequencing Outperforms Multi-Gene Panels for Patients with Epilepsy

Down -38.07% in 4 Weeks, Here's Why You Should You Buy the Dip in Trevi Therapeutics, Inc. (TRVI)
BIAF

Zacks

a year ago

Down -38.07% in 4 Weeks, Here's Why You Should You Buy the Dip in Trevi Therapeutics, Inc. (TRVI)

BIAF

ACCESSWIRE

a year ago

Vivakor Reports 39% Revenue Growth to $16.3 Million Revenue for Third Quarter 2023

CMS Posts Final Payment Determination for bioAffinity Technologies’ CyPath® Lung Effective January 2024
BIAF

Business Wire

a year ago

CMS Posts Final Payment Determination for bioAffinity Technologies’ CyPath® Lung Effective January 2024

bioAffinity Technologies VP David Elzi, Ph.D., Named to American Society for Cell Biology Post
BIAF

Business Wire

a year ago

bioAffinity Technologies VP David Elzi, Ph.D., Named to American Society for Cell Biology Post

Old Point Financial Corporation Declares Quarterly Dividend
BIAF

PR Newswire

a year ago

Old Point Financial Corporation Declares Quarterly Dividend

Lead Real Estate Co., Ltd Reports Fiscal 2023 Year-end Financial Results
BIAF

GlobeNewswire

a year ago

Lead Real Estate Co., Ltd Reports Fiscal 2023 Year-end Financial Results

CPI Aerostructures Receives $4.4M Orders from Embraer for Engine Inlet Assemblies
BIAF

GlobeNewswire

a year ago

CPI Aerostructures Receives $4.4M Orders from Embraer for Engine Inlet Assemblies

Leap Therapeutics to Participate at Piper Sandler 35th Annual Healthcare Conference
BIAF

PR Newswire

a year ago

Leap Therapeutics to Participate at Piper Sandler 35th Annual Healthcare Conference

BIAF

ACCESSWIRE

a year ago

Vivakor Announces Results of Special Meeting of Shareholders with All Proposals Approved with Greater than 90% Voted For Each Proposal

Farmer Bros (NASDAQ:FARM) investors are sitting on a loss of 89% if they invested five years ago
BIAF

Simply Wall St.

a year ago

Farmer Bros (NASDAQ:FARM) investors are sitting on a loss of 89% if they invested five years ago

bioAffinity Technologies Teams with American Cancer Society to Raise Funds for Lung Cancer Screening
BIAF

Business Wire

a year ago

bioAffinity Technologies Teams with American Cancer Society to Raise Funds for Lung Cancer Screening

bioAffinity Technologies Reports Third Quarter 2023 Financial Results and Provides Business Update
BIAF

Business Wire

a year ago

bioAffinity Technologies Reports Third Quarter 2023 Financial Results and Provides Business Update

Trevi Therapeutics, Inc. (TRVI) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?
BIAF

Zacks

a year ago

Trevi Therapeutics, Inc. (TRVI) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?

Individual investors account for 54% of Genenta Science S.p.A.'s (NASDAQ:GNTA) ownership, while insiders account for 30%
BIAF

Simply Wall St.

a year ago

Individual investors account for 54% of Genenta Science S.p.A.'s (NASDAQ:GNTA) ownership, while insiders account for 30%

Hour Loop Reports Third Quarter 2023 Results
BIAF

GlobeNewswire

a year ago

Hour Loop Reports Third Quarter 2023 Results

Heritage Global Inc. Just Missed Earnings - But Analysts Have Updated Their Models
BIAF

Simply Wall St.

a year ago

Heritage Global Inc. Just Missed Earnings - But Analysts Have Updated Their Models

BIAF

Thomson Reuters StreetEvents

a year ago

Q3 2023 Achieve Life Sciences Inc Earnings Call

Smart Sand, Inc. (NASDAQ:SND) Q3 2023 Earnings Call Transcript
BIAF

Insider Monkey

a year ago

Smart Sand, Inc. (NASDAQ:SND) Q3 2023 Earnings Call Transcript

Sensus Healthcare to Host Third Quarter 2023 Financial Results and Business Update Conference Call on Thursday, November 9, 2023
BIAF

GlobeNewswire

a year ago

Sensus Healthcare to Host Third Quarter 2023 Financial Results and Business Update Conference Call on Thursday, November 9, 2023

BIAF

ACCESSWIRE

a year ago

Vivakor Issues Shareholder Update

Share on Social Networks: